Adan Medical Innovation develops digital solutions to help patients carrying autoinjectors manage their condition. Our first product, anAPPhylaxis, is a smart case & APP for allergic individuals that have to carry at all times 2 epinephrine autoinjectors to prevent death in case of anaphylaxis, an extreme allergic reaction. Our clinical study (100 patients, 6 months) has demonstrated that our technology modifies patient behavior, shows a statistically significant reduction of anaphylaxis, and better compliance and quality of life. In addition, the Big data potential of our solution is very important, adding real value to it. Our technology has CE Mark, and we plan to launch in Europe in 2019, followed by US market. Our pipeline includes a smartwatch for pediatric populations and a smartbox for public spaces.